Abstract
Ductal carcinoma in-situ (DCIS) presents a risk of transformation to malignant intraductal carcinoma (IDC) of the breast. Three tumor suppressor genes RB, BRCA1 and TP53 are critical in curtailing the progress of DCIS to IDC. The complex transition process from DCIS to IDC involves acquisition of intracellular genomic aberrations and consequent changes in phenotypic characteristics and protein expression level of the cells. The spatiotemporal dynamics associated with breech of epithelial basement membrane and subsequent invasion of stromal tissues during the transition is less understood. We explore the emergence of invasive behavior in benign tumors, emanating from altered expression levels of the three critical genes. A multiscale mechanistic model based on Glazier-Graner-Hogeweg method-based modelling (GGH) is used to unravel the phenotypical and biophysical dynamics promoting the invasive nature of DCIS. Ductal morphologies including comedo, hyperplasia and DCIS, evolve spontaneously from the interplay between the gene activity parameters in the simulations. The spatiotemporal model elucidates the cause-and-effect relationship between cell-level biological signaling and tissue-level biophysical response in the ductal microenvironment. The model predicts that BRCA1 mutations will act as a facilitator for DCIS to IDC transitions while mutations in RB act as initiator of such transitions.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gorringe, K.L., Fox, S.B.: Ductal carcinoma in situ biology, biomarkers, and diagnosis. Front Oncol 7, 248 (2017)
Cowell, C.F., et al.: Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol 7, 859–869 (2013)
Ma, X.-J., et al.: Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. 100, 5974–5979 (2003)
Aubele, M.M., et al.: Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn. Mol. Pathol. 9, 14–19 (2000)
Volinia, S., et al.: Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl. Acad. Sci. 109, 3024–3029 (2012)
Boughey, J.C., Gonzalez, R.J., Bonner, E., Kuerer, H.M.: Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 12, 1276–1287 (2007)
Kurbel, S., Marjanović, K., Dmitrović, B.: A model of immunohistochemical differences between invasive breast cancers and DCIS lesions tested on a consecutive case series of 1248 patients. Theor. Biol. Med. Model. 11, 29 (2014)
Brentani: Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncology Reports 23 (2009)
Megha, T., et al.: p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J. Clin. Pathol. 55, 461–466 (2002)
Gauthier, M.L., et al.: Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12, 479–491 (2007)
Witkiewicz, A.K., et al.: Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am. J. Pathol. 179, 1171–1178 (2011)
Wang, X., et al.: p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer. Hum Pathol 68, 22–25 (2017)
Kumar, P., et al.: Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution. PLoS Genet. 8, e1003027 (2012)
Palm, M.M., Merks, R.M.: Large-scale parameter studies of cell-based models of tissue morphogenesis using CompuCell3D or VirtualLeaf. Tissue Morphogenesis: Methods and Protocols 301–322 (2015)
Anderson, A.R., Chaplain, M.: Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857–899 (1998)
Thorne, B.C., Bailey, A.M., Peirce, S.M.: Combining experiments with multi-cell agent-based modeling to study biological tissue patterning. Brief. Bioinform. 8, 245–257 (2007)
Bailey, A.M., Thorne, B.C., Peirce, S.M.: Multi-cell agent-based simulation of the microvasculature to study the dynamics of circulating inflammatory cell trafficking. Ann. Biomed. Eng. 35, 916–936 (2007)
Qiao, M., Wu, D., Carey, M., Zhou, X., Zhang, L.: Multi-scale agent-based multiple myeloma cancer modeling and the related study of the balance between osteoclasts and osteoblasts. PLoS ONE 10, e0143206 (2015)
Sun, X., Zhang, L., Tan, H., Bao, J., Strouthos, C., Zhou, X.: Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC Bioinformatics 13, 218 (2012)
Macklin, P., Edgerton, M.E., Thompson, A.M., Cristini, V.: Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J. Theor. Biol. 301, 122–140 (2012)
Boghaert, E., Radisky, D.C., Nelson, C.M.: Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state. PLoS Comput. Biol. 10, e1003997 (2014)
Swat, M.H., Thomas, G.L., Belmonte, J.M., Shirinifard, A., Hmeljak, D., Glazier, J.A.: Multi-scale modeling of tissues using CompuCell 3D. Methods Cell Biol. 110, 325–366 (2012)
Rattan, S.I.: Theories of biological aging: genes, proteins, and free radicals. Free Radical Res. 40, 1230–1238 (2006)
Davis, J.D., Lin, S.-Y.: DNA damage and breast cancer. World J. Clin. Oncol. 2, 329–338 (2011)
Gaweł-Bęben, K., et al.: TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer. Cell Biology International n/a-n/a
Norton, K.-A., Popel, A.S.: An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location. J. R. Soc. Interface 11, 20140640 (2014)
Giacinti, C., Giordano, A.: RB and cell cycle progression. Oncogene 25, 5220–5227 (2006)
Yoshida, K., Miki, Y.: Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95, 866–871 (2004)
Fridman, J.S., Lowe, S.W.: Control of apoptosis by p53. Oncogene 22, 9030 (2003)
Corbin, E.A., Adeniba, O.O., Cangellaris, O.V., King, W.P., Bashir, R.: Evidence of differential mass change rates between human breast cancer cell lines in culture. Biomed. Microdevice 19(1), 1–7 (2017). https://doi.org/10.1007/s10544-017-0151-x
Starcevic, S.L., Diotte, N.M., Zukowski, K.L., Cameron, M.J., Novak, R.F.: Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol. Sci. 75, 74–81 (2003)
Knudsen, E.S., et al.: Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression. JNCI: J. Natl. Can. Inst. 104, 1825–1836 (2012)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Sheraton, V.M., Ma, S. (2022). Exploring Ductal Carcinoma In-Situ to Invasive Ductal Carcinoma Transitions Using Energy Minimization Principles. In: Groen, D., de Mulatier, C., Paszynski, M., Krzhizhanovskaya, V.V., Dongarra, J.J., Sloot, P.M.A. (eds) Computational Science – ICCS 2022. ICCS 2022. Lecture Notes in Computer Science, vol 13350. Springer, Cham. https://doi.org/10.1007/978-3-031-08751-6_27
Download citation
DOI: https://doi.org/10.1007/978-3-031-08751-6_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08750-9
Online ISBN: 978-3-031-08751-6
eBook Packages: Computer ScienceComputer Science (R0)